Menu

Refactual

We publish EVERYTHING sent to publish@refactual.com

Boehringer, MD Anderson Form Virtual R&D Center, Samsung BioLogics Expands Bio-Mfg. Capabilities, and More in Today’s CP Direct!

 

Boehringer, MD Anderson Form Virtual R&D Center, Samsung BioLogics Expands Bio-Mfg. Capabilities, and More in Today’s CP Direct!
 Trouble viewing this email? Read it online
Follow us on:       
August 14, 2019
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites

FEATURED NEWS


Boehringer Ingelheim, MD Anderson Form Virtual Cancer R&D Center
New potential gastrointestinal and lung cancer therapies from Boehringer’s pipeline will be combined with MD’s drug development capabilities
Read More >>

Samsung BioLogics Expands Biomanufacturing Capabilities
Implements large scale N-1 perfusion for commercial application
Read More >>

SEKISUI XenoTech Celebrates 25 Years in the US and 64 in Japan!
Read about their journey from small Kansas academic research lab to global Contract Research Organization, as well as their sister lab’s path to becoming the top ADME CRO in Japan.
Read More >>

LATEST STORIES


Frontage Clinical Expands NJ Facilities
Can now accommodate tobacco and nicotine-related studies
Read More >>

Reed-Lane Opens Cold Chain Room for Vial and Ampule Kitting
New facet helps expand service offerings into biopharma sector
Read More >>

Biopharmaceuticals & Analytical Testing Technology
Analytical technology and processes are evolving as the biologics industry continues to grow. Read Contract Pharma’s Exclusive Digital Edition to learn more.
Access Now >>

Schreiner MediPharm, Applied DNA Offer Forensic Authentication Feature
SigNature is based on DNA markers which are deemed to be impossible to counterfeit and recognized as forensic authentication evidence in courts of law
Read More >>

CDMO Indena Improves Manufacturing Process
Jaguar Health’s manufacturing partner to support expanded crofelemer manufacturing volume
Read More >>

Caladrius, Cognate Ink Clinical Manufacturing Agreement
For phase 3 trial of CLBS14 in no-option refractory disabling angina
Read More >>

   
CURRENT ISSUE
July/August 2019

Latest Issue Check out the feature
content
from the latest issue.

WHITEPAPER SPOTLIGHT

 

meet-iqvia

Hot Melt Extrusion for Oral Solid Dosage Forms
Released by: Lubrizol LifeSciences
HME is an efficient and trusted tool that improves solubility and enables the development of oral solid dosage forms from BCS Class II and IV compounds.

Microsite Spotlight

meet-iqvia
Baxter BioPharma Solutions
Baxter’s BioPharma Solutions business collaborates with pharmaceutical companies to support commercialization objectives for their molecules.
White Papers / Tech Papers



We hope you enjoyed this edition of Contract Pharma Direct’s Newsletter

You are receiving this message because you opted in at contractpharma.com. To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address (cp@email.contractpharma.com) to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Montvale, NJ 07645 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2019 Contract Pharma All rights reserved.


Comments

Like!! I blog quite often and I genuinely thank you for your information. The article has truly peaked my interest.

Leave a Reply